drugset / Trial / NCT02159352

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

NCT02159352

Phase 1 Completed 49 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to determine whether multiple doses of darunavir/ritonavir or lopinavir/ritonavir affect the pharmacokinetics of daclatasvir in healthy participants.

Timeline

Start
2014-06
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Daclatasvir Small molecule Oral
Subject Darunavir Small molecule Oral
Subject Lopinavir/Ritonavir Unknown Oral
Subject Ritonavir Other / unclassified Oral